195 related articles for article (PubMed ID: 1856924)
1. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.
Klän R; Loy V; Huland H
J Urol; 1991 Aug; 146(2):316-8. PubMed ID: 1856924
[TBL] [Abstract][Full Text] [Related]
2. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
3. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
4. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level.
Wettstein MS; Baxter NN; Sutradhar R; Mamdani M; Song P; Qadri SR; Bhalla G; Li K; Liu N; van der Kwast T; Hermanns T; Kulkarni GS
J Urol; 2022 Feb; 207(2):314-323. PubMed ID: 34547923
[TBL] [Abstract][Full Text] [Related]
6. [Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma].
Vögeli TA; Grimm MO; Simon X; Ackermann R
Urologe A; 2002 Sep; 41(5):470-4. PubMed ID: 12426865
[TBL] [Abstract][Full Text] [Related]
7. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
8. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
[TBL] [Abstract][Full Text] [Related]
9. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
Grimm MO; Steinhoff C; Simon X; Spiegelhalder P; Ackermann R; Vogeli TA
J Urol; 2003 Aug; 170(2 Pt 1):433-7. PubMed ID: 12853793
[TBL] [Abstract][Full Text] [Related]
10. The value of a second transurethral resection in evaluating patients with bladder tumors.
Herr HW
J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
[TBL] [Abstract][Full Text] [Related]
11. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
Sivalingam S; Probert JL; Schwaibold H
BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
[No Abstract] [Full Text] [Related]
12. Impact of a second transurethral resection on the staging of T1 bladder cancer.
Dalbagni G; Herr HW; Reuter VE
Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
[TBL] [Abstract][Full Text] [Related]
13. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
[TBL] [Abstract][Full Text] [Related]
14. A second-look TUR in T1 transitional cell carcinoma: why?
Jakse G; Algaba F; Malmström PU; Oosterlinck W
Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
[TBL] [Abstract][Full Text] [Related]
15. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
16. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists.
Zurkirchen MA; Sulser T; Gaspert A; Hauri D
Urol Int; 2004; 72(2):99-102. PubMed ID: 14963348
[TBL] [Abstract][Full Text] [Related]
17. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
18. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
[TBL] [Abstract][Full Text] [Related]
19. Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro.
Herr HW
J Urol; 2011 Sep; 186(3):787-8. PubMed ID: 21788040
[No Abstract] [Full Text] [Related]
20. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]